Inspira Technologies Oxy BHN (IINN) has released an update.
Inspira Technologies Oxy BHN Ltd., a leader in respiratory support technology, has announced the development of a new disposable kit designed to improve safety and patient care by monitoring performance during use. The kit, aimed at the $1 billion perfusion systems market, will be compatible with Inspira’s FDA-cleared INSPIRA ART100 system and other life support machines. With plans to seek FDA clearance for the disposable kit, Inspira aims to deploy the first devices in the U.S. by the end of 2024, marking a significant advancement in its strategy to generate recurring revenues.
For further insights into IINN stock, check out TipRanks’ Stock Analysis page.
